Income Statement (ASTRIA/THERAPEUTICS)

Technical Analysis Historical Data Financials News & Analysis

ASTRIA/THERAPEUTICS NEWS

Astria Therapeutics, Inc. (NASDAQ:ATXS) Receives Consensus Rating of “Buy” from Analysts By MarketBeat - 2 days ago

Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) has earned a consensus rating of “Buy” from the seven ratings firms that are covering the firm, MarketBeat.com reports. Five equities researc… [+3728 chars]...

Read more
4,600 Shares in Astria Therapeutics, Inc. (NASDAQ:ATXS) Purchased by KLP Kapitalforvaltning AS By MarketBeat - 2 weeks ago

KLP Kapitalforvaltning AS purchased a new position in Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm purchased 4,600 shares of th… [+3947 chars]...

Read more
Brokerages Set Astria Therapeutics, Inc. (NASDAQ:ATXS) Target Price at $26.60 By MarketBeat - 4 weeks ago

Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) has received an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. … [+4007 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		181.82 -0.18
-0.1%
CVX 		135.27 -4.03
-2.89%
CAT 		303.6 -3.8
-1.24%
INTC 		19.8 -0.54
-2.68%
MSFT 		390.02 -4.02
-1.02%
DIS 		89.85 -1.32
-1.45%
DOW 		29.97 -0.69
-2.23%
CSCO 		57.22 -0.13
-0.22%
GS 		543.14 -5.78
-1.05%